Don D Sin1, S F Paul Man, Thomas J Marrie. 1. James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, Department of Medicine (Pulmonary Division), University of British Columbia, Vancouver, Canada. dsin@mrl.ubc.ca
Abstract
PURPOSE: Respiratory failure is the leading cause of death among patients admitted with community-acquired pneumonia. We sought to determine the association between arterial carbon dioxide tension (P(a)CO(2)) and in-hospital mortality in patients admitted with pneumonia. METHODS: We analyzed data from 2171 patients aged >or=17 years who had been admitted for community-acquired pneumonia to an acute care hospital in Edmonton, Alberta. We compared the risk of all-cause in-hospital mortality using a Cox proportional hazards model across categories of P(a)CO(2). RESULTS: Overall, in-hospital mortality was 10% (n = 218). Compared with patients with normal P(a)CO(2) values (40 to 44 mm Hg), in-hospital mortality was greater (adjusted odds ratio [OR] = 1.8; 95% confidence interval [CI]: 1.0 to 3.2) among patients with hypocapnia (P(a)CO(2) <32 mm Hg). In-hospital mortality was also greater (OR = 2.6; 95% CI: 1.5 to 4.5) in patients with hypercapnia (>or=45 mm Hg). In-hospital mortality was similar in patients with P(a)CO(2) values between 32 and 35 mm Hg (OR = 1.55; 95% CI: 0.89 to 2.79) and those with values between 36 and 39 mm Hg (OR = 1.42; 95% CI: 0.77 to 2.61). CONCLUSION: Among patients admitted with community-acquired pneumonia, in-hospital mortality was greater in those with hypocapnia or hypercapnia. These data suggest that measurement of P(a)CO(2) adds prognostic information to standard prediction rules and should be used for clinical and epidemiologic purposes to risk-stratify in-hospital patients with community-acquired pneumonia.
PURPOSE:Respiratory failure is the leading cause of death among patients admitted with community-acquired pneumonia. We sought to determine the association between arterial carbon dioxide tension (P(a)CO(2)) and in-hospital mortality in patients admitted with pneumonia. METHODS: We analyzed data from 2171 patients aged >or=17 years who had been admitted for community-acquired pneumonia to an acute care hospital in Edmonton, Alberta. We compared the risk of all-cause in-hospital mortality using a Cox proportional hazards model across categories of P(a)CO(2). RESULTS: Overall, in-hospital mortality was 10% (n = 218). Compared with patients with normal P(a)CO(2) values (40 to 44 mm Hg), in-hospital mortality was greater (adjusted odds ratio [OR] = 1.8; 95% confidence interval [CI]: 1.0 to 3.2) among patients with hypocapnia (P(a)CO(2) <32 mm Hg). In-hospital mortality was also greater (OR = 2.6; 95% CI: 1.5 to 4.5) in patients with hypercapnia (>or=45 mm Hg). In-hospital mortality was similar in patients with P(a)CO(2) values between 32 and 35 mm Hg (OR = 1.55; 95% CI: 0.89 to 2.79) and those with values between 36 and 39 mm Hg (OR = 1.42; 95% CI: 0.77 to 2.61). CONCLUSION: Among patients admitted with community-acquired pneumonia, in-hospital mortality was greater in those with hypocapnia or hypercapnia. These data suggest that measurement of P(a)CO(2) adds prognostic information to standard prediction rules and should be used for clinical and epidemiologic purposes to risk-stratify in-hospital patients with community-acquired pneumonia.
Authors: Ziyan Lu; S Marina Casalino-Matsuda; Aisha Nair; Anja Buchbinder; G R Scott Budinger; Peter H S Sporn; Khalilah L Gates Journal: FASEB J Date: 2018-02-05 Impact factor: 5.191
Authors: I K Zöllner; S K Weiland; I Piechotowski; T Gabrio; E von Mutius; B Link; G Pfaff; B Kouros; J Wuthe Journal: Thorax Date: 2005-07 Impact factor: 9.139
Authors: István Vadász; Rolf D Hubmayr; Nicolás Nin; Peter H S Sporn; Jacob I Sznajder Journal: Am J Respir Cell Mol Biol Date: 2012-01-12 Impact factor: 6.914
Authors: S Marina Casalino-Matsuda; Aisha Nair; Greg J Beitel; Khalilah L Gates; Peter H S Sporn Journal: J Immunol Date: 2015-04-20 Impact factor: 5.422
Authors: Naizhen Wang; Khalilah L Gates; Humberto Trejo; Silvio Favoreto; Robert P Schleimer; Jacob I Sznajder; Greg J Beitel; Peter H S Sporn Journal: FASEB J Date: 2010-02-24 Impact factor: 5.191
Authors: Nicolas Nin; Alfonso Muriel; Oscar Peñuelas; Laurent Brochard; José Angel Lorente; Niall D Ferguson; Konstantinos Raymondos; Fernando Ríos; Damian A Violi; Arnaud W Thille; Marco González; Asisclo J Villagomez; Javier Hurtado; Andrew R Davies; Bin Du; Salvatore M Maggiore; Luis Soto; Gabriel D'Empaire; Dimitrios Matamis; Fekri Abroug; Rui P Moreno; Marco Antonio Soares; Yaseen Arabi; Freddy Sandi; Manuel Jibaja; Pravin Amin; Younsuck Koh; Michael A Kuiper; Hans-Henrik Bülow; Amine Ali Zeggwagh; Antonio Anzueto; Jacob I Sznajder; Andres Esteban Journal: Intensive Care Med Date: 2017-01-20 Impact factor: 17.440
Authors: Brian W Roberts; Nicholas M Mohr; Enyo Ablordeppey; Anne M Drewry; Ian T Ferguson; Stephen Trzeciak; Marin H Kollef; Brian M Fuller Journal: Crit Care Med Date: 2018-03 Impact factor: 7.598
Authors: Eoin P Cummins; Andrew C Selfridge; Peter H Sporn; Jacob I Sznajder; Cormac T Taylor Journal: Cell Mol Life Sci Date: 2013-09-18 Impact factor: 9.261
Authors: Iiro Taneli Helenius; Ryan J Haake; Yong-Jae Kwon; Jennifer A Hu; Thomas Krupinski; S Marina Casalino-Matsuda; Peter H S Sporn; Jacob I Sznajder; Greg J Beitel Journal: J Immunol Date: 2015-12-07 Impact factor: 5.422